Cyclin-Dependent Kinase Subunit 2 (CKS2) as a Prognostic Marker for Stages I–III Invasive Non-Mucinous Lung Adenocarcinoma and Its Role in Affecting Drug Sensitivity

With the aim of improving the prognosis of patients with lung adenocarcinoma (LUAD), we identified the biomarker related to the sensitivity of patients to chemotherapy drugs and explored the potential mechanisms. As a cell cycle-related protein, CKS2 has an essential role to play in tumor progressio...

Descripción completa

Detalles Bibliográficos
Autores principales: Feng, Junkai, Hu, Menglong, Li, Zongkuo, Hu, Guiming, Han, Yuting, Zhang, Yan, Zhang, Min, Ren, Jingli
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9406629/
https://www.ncbi.nlm.nih.gov/pubmed/36010686
http://dx.doi.org/10.3390/cells11162611

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9406629/
https://www.ncbi.nlm.nih.gov/pubmed/36010686
http://dx.doi.org/10.3390/cells11162611

Ejemplares similares